Angelini Pharma researches, develops and markets health solutions with a predominant focus on the areas of Brain Health, including Mental Health and Epilepsy, Consumer Healthcare, Specialty and Primary Care.
Angelini Ventures is the corporate venture capital that employs the Group’s know-how to create, support and invest in startups and innovative companies, contributing to the transformation of current care practices and the creation of integrated healthcare platforms.